News
5h
Zacks Investment Research on MSNTarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue EstimatesTarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $1.01 per share a year ago. These ...
This week we explore recent discoveries about the mysterious Denisovans that are causing scientists to rethink humanity's ...
The project also shows that mammoths in the Modern Late Pleistocene fell into three genetic groups, all of which shared a most recent common ancestor around 780,000 years ago. Notably, this loosely ...
A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and ...
The enigmatic Y chromosome has a tendency to disappear from cells with age. Now, research is revealing the long-term impacts this can have on disease risk and life expectancy ...
When scouting for the draft, Howie Roseman and the Eagles believe there are real benefits to players with NFL bloodlines.
Andrés Aguilera's laboratory, in collaboration with that of Ralf Wellinger (both professors in the Department of Genetics at ...
Researchers have identified two natural compounds, patulin and xestoquinol, as new inhibitors of the enzyme topoisomerase 1, ...
Surveys by the Brazilian Animal Protein Association (ABPA) show that Brazilian exports of poultry genetics (fertile eggs and ...
A rare disorder called myotonic dystrophy type 1 (DM1) causes weakness and muscle loss that gets progressively worse... | ...
Another good reason for taking Social Security at 62 is that you have health problems that don't allow you to work full-time.
Gypsy Rose Blanchard revealed that her daughter, Aurora, tested negative for 1q21.1 microdeletion, which is a genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results